Expression of bone turnover markers in patients with tuboovarian carcinoma exposed to platinum-based chemotherapy ± bevacizumab

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Huhmann, A. [1 ]
Herz, S. [1 ]
Kurbacher, A. T. [1 ]
Monreal, K. [1 ]
Kurbacher, J. A. [2 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Gynecol Oncol, Bonn, Germany
[2] Gynecol Ctr Bonn Friedenspl, Gen Gynecol & Obstet, Bonn, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0268
引用
收藏
页码：750 / 750
页数：1
相关论文
共 50 条
  • [21] The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
    Bamias, A
    Efstathiou, E
    Moulopoulos, LA
    Gika, D
    Hamilos, G
    Zorzou, MP
    Kakoyiannis, C
    Kastritis, E
    Bozas, G
    Papadimitriou, C
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 307 - 313
  • [22] Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
    Malandrino, Pasqualino
    Al Ghuzlan, Abir
    Castaing, Marine
    Young, Jacques
    Caillou, Bernard
    Travagli, Jean-Paul
    Elias, Dominique
    de Baere, Thierry
    Dromain, Clarisse
    Paci, Angelo
    Chanson, Philippe
    Schlumberger, Martin
    Leboulleux, Sophie
    Baudin, Eric
    ENDOCRINE-RELATED CANCER, 2010, 17 (03) : 797 - 807
  • [23] Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma
    Yumioka, Tetsuya
    Honda, Masashi
    Shimizu, Ryutaro
    Teraoka, Shogo
    Yamaguchi, Noriya
    Kawamoto, Bunya
    Iwamoto, Hideto
    Morizane, Shuichi
    Hikita, Katsuya
    Takenaka, Atsushi
    ANTICANCER RESEARCH, 2021, 41 (11) : 5767 - 5773
  • [24] Do elderly patients with advanced urothelial carcinoma benefit from platinum-based chemotherapy?
    Hans von der Maase
    Nature Clinical Practice Urology, 2005, 2 : 318 - 319
  • [25] Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma
    Nakamura, Y
    Kunitoh, H
    Kubota, K
    Sekine, I
    Shinkai, T
    Tamura, T
    Kodama, T
    Sumi, M
    Kohno, S
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (09) : 385 - 388
  • [26] MULTIPLE BIOLOGICAL MARKERS IN GERM-CELL TUMOR PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY
    PERERA, FP
    MOTZER, RJ
    TANG, D
    REED, E
    PARKER, R
    WARBURTON, D
    ONEILL, P
    ALBERTINI, R
    BIGBEE, WL
    JENSEN, RH
    SANTELLA, R
    TSAI, WY
    SIMONCEREIJIDO, G
    RANDALL, C
    BOSL, G
    CANCER RESEARCH, 1992, 52 (13) : 3558 - 3565
  • [27] Expression of UCP2 is associated with the sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Inoue, Yuta
    Fukuda, Takeshi
    Kawanishi, Masaru
    Shimomura, Masahiro
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S9 - S9
  • [28] Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy
    Ronchi, Cristina L.
    Sbiera, Silviu
    Kraus, Luitgard
    Wortmann, Sebastian
    Johanssen, Sarah
    Adam, Patrick
    Willenberg, Holger S.
    Hahner, Stefanie
    Allolio, Bruno
    Fassnacht, Martin
    ENDOCRINE-RELATED CANCER, 2009, 16 (03) : 907 - 918
  • [29] Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Kawanishi, Masaru
    Fukuda, Takeshi
    Shimomura, Masahiro
    Inoue, Yuta
    Wada, Takuma
    Tasaka, Reiko
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2018, 15 (06) : 9923 - 9928
  • [30] Phase II Study of Temozolomide Monotherapy in Patients of Neuroendocrine Carcinoma with Resistant to Platinum-Based Chemotherapy
    Ichikawa, Y.
    Kobayashi, N.
    Tokuhisa, M.
    Goto, A.
    Hiroshima, Y.
    NEUROENDOCRINOLOGY, 2018, 106 : 196 - 196
12345